Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group
| Autor: | Gupta, Abha A *, Xue, Wei, Harrison, Douglas J, Hawkins, Douglas S, Dasgupta, Roshni, Wolden, Suzanne, Shulkin, Barry, Qumseya, Amira, Routh, Jonathan C, MacDonald, Tamara, Feinberg, Shari, Crompton, Brian, Rudzinski, Erin R, Arnold, Michael, Venkatramani, Raj |
|---|---|
| Zdroj: | In The Lancet Oncology July 2024 25(7):912-921 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|